Comparison of genomic and cDNA sequences of guinea pig CYP2B18 and rat CYP2B2: absence of a phenobarbital-responsive enhancer module in the upstream region of the CYP2B18 gene

Journal of Biochemical and Molecular Toxicology
Midori YamamotoHideyuki Yamada

Abstract

Potential mechanisms were investigated whereby CYP2B18, a cytochrome P450 gene exhibiting high constitutive expression but only low levels of phenobarbital-inducibility in the guinea pig liver, may be differentially regulated versus the highly inducible rat CYP2B2 gene. To comparatively assess potential regulatory sequences associated with CYP2B18, a guinea pig genomic library was screened enabling isolation of the CYP2B18 gene. The genomic screening process resulted in the identification of at least four closely-related CYP2B18 genes, designated here as CYP2B18A-D. Of these isolates, CYP2B18A exhibited sequence identical to that of the CYP2B18 cDNA. Further, the deduced amino acid sequence of the CYP2B18 cDNA was identical to that of N-terminal and internally-derived peptide sequences obtained in this investigation from CYP2B18 protein isolated from guinea pig liver. Genomic structural sequences were derived for CYP2B18A, together with the respective 5'-upstream and intronic regions of the gene. Comparison of the CYP2B18A and CYP2B2 gene sequences revealed the lack of repetitive LINE gene sequences in CYP2B18A, putative silencing elements that effect neighboring genes, although these sequences were present in both 5'-upstream ...Continue Reading

References

Feb 1, 1992·The Biochemical Journal·D J Waxman, L Azaroff
May 15, 1991·Archives of Biochemistry and Biophysics·K OguriH Yoshimura
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L LaiminsG Khoury
Jun 6, 1997·The Journal of Biological Chemistry·P Honkakoski, M Negishi
Feb 26, 1999·The Journal of Biological Chemistry·T SueyoshiM Negishi
Apr 26, 2000·Genome Research·S SchwartzW Miller

❮ Previous
Next ❯

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.